Mehra Anand
Director at Spark Therapeutics, Inc.; Director at ACRS; Director at AERIE PHARMACEUTICALS INC
- Sold, on record
- $171M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Jul 24, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- Spark Therapeutics, Inc.Director
- ACRSAclaris Therapeutics, Inc.Director
- AERIE PHARMACEUTICALS INCDirector
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- AERIE PHARMACEUTICALS INC2.2M shares
- Spark Therapeutics, Inc.1.6M shares
- ACRS750,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Spark Therapeutics, Inc.Plan not statedFeb 7 2017
Sold 25,334 shares at $65.06 ($1.6M)
Mehra Anand, Director
Sold 2.8% of holdings ($58.9M position)879,652 shares left1x usual sizeFiling
- 2 Form 4 sale Spark Therapeutics, Inc.Plan not statedFeb 9 +2 days
Sold 37,411 shares at $65.06 ($2.4M)
Mehra Anand, Director
Sold 4.3% of holdings ($57.2M position)842,241 shares left1.5x usual sizeFiling
- 3 Form 4 sale Spark Therapeutics, Inc.Plan not statedFeb 16 +7 days
Sold 35,347 shares at $65.03 ($2.3M)
Mehra Anand, Director
Sold 4.2% of holdings ($54.8M position)806,894 shares left1.3x usual sizeFiling
- 4 Form 4 sale Spark Therapeutics, Inc.Plan not statedFeb 17 +1 day
Sold 7,535 shares at $65.01 ($490k)
Mehra Anand, Director
Sold 0.9% of holdings ($52.5M position)799,359 shares left0.3x usual sizeFiling
- 5 Form 4 sale Spark Therapeutics, Inc.UnusualMar 1 +12 days
Sold 84,654 shares at $65.02 ($5.5M)
Mehra Anand, Director
Sold 10.6% of holdings ($52M position)714,705 shares left3.1x usual sizeFiling
- 6 Form 4 sale Spark Therapeutics, Inc.Plan not statedMar 2 +1 day
Sold 15,275 shares at $65.01 ($993k)
Mehra Anand, Director
Sold 2.1% of holdings ($46.5M position)699,430 shares left0.5x usual sizeFiling
- 7 Form 4 sale Spark Therapeutics, Inc.Plan not statedJun 21 +111 days
Sold 6,302 shares at $65.00 ($410k)
Mehra Anand, Director
Sold 0.9% of holdings ($45.5M position)693,128 shares left0.2x usual sizeFiling
- 8 Form 4 sale Spark Therapeutics, Inc.UnusualJul 24 +33 days
Sold 211,858 shares at $70.15 ($14.9M)
Mehra Anand, Director
Sold 30.6% of holdings ($48.6M position)481,270 shares left8.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 211,858 | $14.9M | 30.6% | Unusual | SEC |
| Jun 21, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 6,302 | $410k | 0.9% | Plan not stated | SEC |
| Mar 2, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 15,275 | $993k | 2.1% | Plan not stated | SEC |
| Mar 1, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 84,654 | $5.5M | 10.6% | Unusual | SEC |
| Feb 17, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 7,535 | $490k | 0.9% | Plan not stated | SEC |
| Feb 16, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 35,347 | $2.3M | 4.2% | Plan not stated | SEC |
| Feb 9, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 37,411 | $2.4M | 4.3% | Plan not stated | SEC |
| Feb 7, 2017 | Spark Therapeutics, Inc. | Director | Form 4 sale | 25,334 | $1.6M | 2.8% | Plan not stated | SEC |
| Jan 10, 2017 | ACRS | Director | Form 4 sale | 750,000 | $21.2M | 32.8% | Unusual | SEC |
| Dec 16, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 349,656 | $18.7M | 27.9% | Unusual | SEC |
| Dec 13, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 122,532 | $6.8M | 8.9% | Unusual | SEC |
| Aug 11, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 29,963 | $1.8M | 2.1% | Plan not stated | SEC |
| Aug 8, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 100 | $6k | 0.0% | Plan not stated | SEC |
| Aug 4, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 5,064 | $304k | 0.4% | Plan not stated | SEC |
| Aug 1, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 22,665 | $1.4M | 1.6% | Plan not stated | SEC |
| May 31, 2016 | Spark Therapeutics, Inc. | Director | Form 4 sale | 500 | $30k | 0.0% | Plan not stated | SEC |
| Nov 27, 2015 | Spark Therapeutics, Inc. | Director | Form 4 sale | 22,961 | $1.4M | 1.6% | Plan not stated | SEC |
| Nov 12, 2015 | Spark Therapeutics, Inc. | Director | Form 4 sale | 130,605 | $7.9M | 8.2% | Plan not stated | SEC |
| Oct 8, 2015 | Spark Therapeutics, Inc. | Director | Form 4 sale | 529,544 | $24.1M | 25.0% | Plan not stated | SEC |
| Apr 15, 2015 | AERIE PHARMACEUTICALS INC | Director | Form 4 sale | 425,000 | $14.3M | 47.5% | Unusual | SEC |
| Nov 25, 2014 | AERIE PHARMACEUTICALS INC | Director | Form 4 sale | 800,000 | $20.8M | 51.1% | Unusual | SEC |
| Jul 10, 2014 | AERIE PHARMACEUTICALS INC | 10% owner | Form 4 sale | 1M | $24.2M | 100.0% | Unusual | SEC |